Fate Therapeutics, Inc. Share Price
FATEFate Therapeutics, Inc. Stock Performance
Open $1.93 | Prev. Close $1.92 | Circuit Range N/A |
Day Range $1.82 - $2.09 | Year Range $0.91 - $2.88 | Volume 1,09,009 |
Average Traded $1.93 |
Fate Therapeutics, Inc. Share Price Chart
About Fate Therapeutics, Inc.
Fate Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops programmed cellular immunotherapies for cancer and immune disorders in the United States and internationally. The company's chimeric antigen receptor (CAR)-targeted NK and T-cell product candidates include FT576 to treat multiple myeloma; FT836 whiuch is in preclinical stage for multiple tumor types; and FT522, to treat B-cell Lymphoma and autoimmunity. Its CAR T-cell programs include FT819 to treat systemic lupus erythematosus, and FT825 to treat solid tumors.It has a collaboration and option agreement with Ono Pharmaceutical Co. Ltd. for the development and commercialization of off-the-shelf, iPSC-derived CAR T-cell product candidates for the treatment of solid tumors. Fate Therapeutics, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Fate Therapeutics, Inc. Historical Data
| Day | Open | Close | Change % |
|---|---|---|---|
09-Jun-26 | $1.93 | $1.90 | +0.00% |
09-Jun-26 | $1.93 | $1.90 | -0.26% |
08-Jun-26 | $1.99 | $1.90 | -3.80% |
05-Jun-26 | $2.17 | $1.98 | -10.63% |
04-Jun-26 | $2.23 | $2.21 | +0.45% |
03-Jun-26 | $2.49 | $2.20 | -14.23% |
02-Jun-26 | $2.67 | $2.56 | -6.22% |
FAQs on Fate Therapeutics, Inc. Share Price
Can I buy Fate Therapeutics, Inc. shares in India?
What is the share price of Fate Therapeutics, Inc.?
What is the 5 year returns of Fate Therapeutics, Inc.?
What are the high & low stock price of Fate Therapeutics, Inc. today?
What is the 52-week high and low of Fate Therapeutics, Inc. stock?